INDONESIAN JOURNAL OF PHARMACEUTICAL AND CLINICAL RESEARCH

INDONESIAN JOURNAL OF PHARMACEUTICAL AND CLINICAL RESEARCH

 

INSTRUCTION FOR AUTHORS

Indonesian Journal of Pharmaceutical and Clinical Research (IJPCR)[i-[1] is a-peer-reviewed publication of original research works. The mission of the journal is to offer a medium to exchange ideas and information about the advancement of knowledge and research in disciplines of pharmaceutical technology, pharmacology, clinical pharmacy, medical sciences, biological pharmacy, and pharmaceutical chemistry. The journal also receives systematic reviews, meta-analysis and review articles on new issues in pharmaceutical and clinical sciences.Submission to this journal implies that the manuscript has not been published or under consideration to be published in another journal. At the initial stage, this journal will be published online twice a year.

PROCESS OF MANUSCRIPT REVIEW

The incoming manuscripts will be sent to peer-reviewers who are competent in the area of the related topic. Reviewing process for each manuscript takes 2 weeks. Decision made whether the manuscript is rejected, considered to be published upon revision or accepted for publication will be informed to the authors no later than 2 weeks after receiving the comments from the reviewers. The revised manuscript should be sent back to secretariat of IJPCR no later than 2 weeks. Editorials are responsible for all editing before publication.

MANUSCRIPT PREPARATION

The manuscript, including tables, figures, and references should bewritten in English and prepared in Times New Roman with normal margin, 12 font size and 1.5 spaces on A4 (21.5 cm x 28 cm) paper with maximum of 12 pages.

TITLE PAGE

Title page consists of the title of the manuscript, full names of authors with the highest academic degrees, affiliations, mailing addresses, telephone and fax numbers, and e-mail address of the corresponding author. The title should be specific, concise, and informative, clearly related to the aim of the study,written with UPPERCASE and BOLD, and consist of not more than 20 words without abbreviations.

ABSTRACT AND KEYWORDS

Abstract consists of objective, methods, results, and conclusion. It should contain not more than 250 words. Keywords contain 3 to 5 words.

MANUSCRIPT TEXT

Manuscript text consists of introduction, materials and methods, results, discussion, and conclusion.

INTRODUCTION

The introduction provides information on what is known, believed, and unknown about the topic, findings of the relevant studies, and the importance of the study. The objective of the study must be stated in a single sentence in the last paragraph of the introduction.

MATERIALS AND METHODS

Ethical clearance associated with the study must be included. Explains design of the study, how the data were obtained and analyzed. The method must be clearly described to allow the reproduction of the procedures. Specifications of the instrument, drugs, and chemicals should be mentioned.

RESULTS

Describes what was found and answers to the objective of the study.

TABLE AND FIGURE

Tables and figures should be placed after the reference section.The title of a table (with a sentence case) should briefly identify the table and not contain explanatory materials. This should be placed at the top of the table. An explanatory footnote is placed on the table’s note not on table’s title. The table is constructed with subhead and without left and right borders.

Figures should be placed on separate pages with number according to their appearance. A figure’s name (with a sentence case) is placed at its bottom.

DISCUSSION

Describe what the results of the study mean in relation to what was previously known about the subject. Indicate how the results relate to expectations and to the literatures previously cited. Describes the implications of the finding and compared to what were obtained by previous researchers

CONCLUSION

The conclusion is linked back to the aims of the study.

ACKNOWLEDGEMENT

Explains who supported the research and provided the funding.

CONFLICT OF INTEREST

Conflict of interest must be declared by the authors.

REFERENCES

References ensure that the previous findings were recognized. References should be written in accordance with the Vancouver referencing style (number in the order in which they first appear in the text). List the first six authors. When there are more than six authors, list the first six authors followed by et al. Place priority for the last ten years published articles.

Examples:

  1. Article

Manley HJ, Cannella CA, Bailie GR, St Peter WL. Medication-related problems in ambulatory hemodialysis patients: A pooled analysis. Am J Kidney Dis 2005;46(4):669-80.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-52.

  1. Book

DiPiro J, Talbert R, Yee G, Matzke G, Wells B, Posey L. Pharmacotherapy: a pathophysiologic approach 7th Ed. New York: The McGraw-Hill Companies Inc; 2008.

  1. Thesis and dissertation

Dalimunthe A. Evaluasi efek fraksi n-heksan, etil asetat dan etanoldaunpuguntano[i-[2](PicriafelterraeLour.) terhadap sistim kardiovasculer tikus (disertasi). Medan: Universitas Sumatera Utara; 2016.

  1. Proceeding

Nasution A, Syed sulaiman SA, Shafie AA.Drug-related problems and length of stay in the management of infection in patients with chronic kidney disease. Proceeding in ISPOR 5th Asia-Pacific Conference, 2012 September 2-4;Taipei, Taiwan.

  1. Online

Medscape Reference. Assessed online June 16th. Available from: http://www.emedicine.medscape.com/article/241381-medication.

FEE FOR PUBLICATION

All the articles will be published in Indonesian Journal of Pharmaceutical and Clinical Research have to pay Rp 500.000,- per article for Article Processing Charge.


SUBMISSION

You can submit your research article,systematic review, meta-analysis, and review article through mail on This email address is being protected from spambots. You need JavaScript enabled to view it..